Alessandra Bettiol
Overview
Explore the profile of Alessandra Bettiol including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
1138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Damiano R, Della Bona M, Procopio E, Guerrini R, Bettiol A, la Marca G
Clin Chem Lab Med
. 2025 Feb;
PMID: 39900492
Objectives: Pyridoxine-dependent epilepsy (PDE) is a rare genetic disorder characterized by intractable neonatal seizures responsive to pyridoxine. Diagnosis relies on quantification of α-aminoadipic semialdehyde, piperideine-6-carboxylate and pipecolic acid in urine...
2.
Damiano R, Della Bona M, Procopio E, Gasperini S, Guerrini R, Bettiol A, et al.
Clin Chim Acta
. 2024 Dec;
567():120111.
PMID: 39725130
Background: Pyridoxine-dependent epilepsy (PDE) is a rare inborn error of lysine metabolism. To date, diagnosis of PDE relies on the quantification of α-AminoAdipic SemiAldehyde (α- AASA), Piperideine-6-Carboxylate (P6C) and Pipecolic...
3.
Giurranna E, Nencini F, Bettiol A, Borghi S, Argento F, Emmi G, et al.
Int J Mol Sci
. 2024 Nov;
25(21).
PMID: 39519009
Reactive oxygen species (ROS) contribute to endothelial dysfunction, platelet activation, and coagulation abnormalities, promoting thrombus formation. Given the growing interest in non-pharmacological approaches to modulate oxidative stress, we examine the...
4.
Nencini F, Bettiol A, Argento F, Borghi S, Giurranna E, Emmi G, et al.
Mol Biomed
. 2024 Oct;
5(1):45.
PMID: 39477884
Fibrinogen, a blood plasma protein with a key role in hemostasis and thrombosis, is highly susceptible to post-translational modifications (PTMs), that significantly influence clot formation, structure, and stability. These PTMs,...
5.
Oza C, Khadilkar A, Bhor S, Curran K, Sambare C, Ladkat D, et al.
Clin Med Insights Endocrinol Diabetes
. 2024 Sep;
17:11795514241275921.
PMID: 39233877
Objective: There are very few reports on the prevalence of diabetic retinopathy (DR) in children and youth with type-1 diabetes (T1D). Studies have also found very low rates of referral...
6.
Ferrara P, Antonazzo I, Zamparini M, Fornari C, Borrelli C, Boarino S, et al.
Lupus Sci Med
. 2024 May;
11(1).
PMID: 38744457
Objectives: To estimate the incidence and prevalence of SLE in Italy, and to describe the demographic and clinical characteristics of patients with newly diagnosed SLE. Methods: A retrospective cohort study...
7.
Prisco D, Canfora M, Mazzetti M, Mattioli I, Bettiol A
Intern Emerg Med
. 2024 May;
19(7):1807-1819.
PMID: 38743127
Stroke is one of the most common causes of mortality and disability worldwide. Antithrombotic therapy represents the mainstay in primary and secondary prevention, both in cardioembolic and non-cardioembolic stroke. Particularly,...
8.
Emmi G, Bettiol A, Hatemi G, Prisco D
Lancet
. 2024 Feb;
403(10431):1093-1108.
PMID: 38402885
Behçet's syndrome is a rare, chronic multisystemic inflammatory disorder also known as the Silk Route disease due to its geographical distribution. Behçet's syndrome is a multifactorial disease and infectious, genetic,...
9.
Bettiol A, Urban M, Emmi G, Galora S, Argento F, Fini E, et al.
Front Mol Biosci
. 2024 Feb;
10:1325002.
PMID: 38304233
Thrombosis is a major cause of morbidity and mortality worldwide, with a complex and multifactorial pathogenesis. Recent studies have shown that SIRT1, a member of the sirtuin family of NAD...
10.
Bettiol A, Urban M, Padoan R, Groh M, Lopalco G, Egan A, et al.
Lancet Rheumatol
. 2024 Jan;
5(12):e707-e715.
PMID: 38251561
Background: Interleukin-5 (IL-5) inhibitors represent novel therapies for eosinophilic granulomatosis with polyangiitis (EGPA). This study assessed the effectiveness and safety of the IL-5 receptor inhibitor benralizumab in a European cohort...